ArticleBreast (Edinburgh, Scotland)2026

Subcutaneous pertuzumab-trastuzumab: Efficiency, safety, and the biosimilar horizon.

Asim Armagan Aydin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.